TAG:
ameripath
Year-end Financials Released For Quest, LabCorp & LabOne
In RECENT WEEKS, public laboratory companies have released earnings reports for the year-ending December 31, 2004. It was generally a good year for the three largest lab companies that have a major emphasis on providing lab testing services to office-based physicians. In this year’s review, THE DA…
Review of 2004 Lab Sales Identifies Buyer Interest
CEO SUMMARY: Laboratory acquisition activity was surprisingly high during 2004. One reason is that new buyers appeared in the marketplace. However, all buyers have specific acquisition criteria. When a selling lab meets that criteria, it can expect multiple bidders and a strong purchase p…
“January 3, 2005 Intelligence: Late Breaking Lab News”
More evidence of the move to an all computer economy has surfaced. During 2003, consumer use of credit cards, debit cards, and other electronic payment methods eclipsed paper checks for the first time. The study was done by the Federal Reserve Bank of Atlanta. It reports that 36.7 bi…
Change Beneath Surface Marks 2004 Lab Stories
CEO SUMMARY: Presented here are THE DARK REPORT’S “Ten Biggest Lab Stories of 2004.” These are the events we consider most important to the lab industry during the year. However, in contrast to past years, 2004 lacked the types of blockbuster events which radically change and reshap…
Oncology’s Potential Drives AP Lab Expansion
CEO SUMMARY: It is no coincidence that another public company is shifting its business focus and expanding its efforts to capture cancer-related anatomic pathology specimens. Demographic trends predict a steady increase in the number of new cancer cases yearly, while new technologies are …
“July 19, 2004 Intelligence: Late Breaking Lab News”
A transfusion of the wrong type of blood may have contributed to the death of a critically ill woman at Sarasota Memorial Hospital in Sarasota, Florida last month. The patient died about a day after the transfusion. Following the blood transfusion, a reaction had been observed. Atten…
National AP Firms Target Gastroenterology Groups
CEO SUMMARY: It’s a trend as yet invisible to the radar screens of most pathology groups. A new crop of specialty AP companies is targeting gastroenterology. In the past 36 months, several have posted phenomenal growth in both specimen volume and revenue. The heightened competition for …
“May 17, 2004 Intelligence: Late Breaking Lab News”
Oncology is predicted to be a major driver in laboratory testing in coming years (see TDR, March 15, 2004). That said, lung cancer may be the next high-profile target, joining…
New Esoteric Lab Firm Does Two Acquisitions
CEO SUMMARY: Armed with $70 million, American Esoteric Laboratories (AEL) wants to build a national laboratory that offers a full menu of esoteric tests. It is building a primary laboratory in Dallas, which has one of the nation’s best air transport hubs. ThromboCare Laboratories and Vi…
Welsh Carson Pays $1.14 Billion To Acquire U.S. Oncology, Inc.
EVEN AS THE LAST ISSUE of THE DARK REPORT was reaching clients with news of Genzyme Corp.’s offer to buy IMPATH Inc., another big oncology deal was announced. On March 22, 2004, Welsh, Carson, Anderson & Stowe announced an offer of $15.05 per …
CURRENT ISSUE
Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.